These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
236 related articles for article (PubMed ID: 15951457)
1. Decreased use of adjuvant breast cancer therapy in a randomized controlled trial of a decision aid with individualized risk information. Peele PB; Siminoff LA; Xu Y; Ravdin PM Med Decis Making; 2005; 25(3):301-7. PubMed ID: 15951457 [TBL] [Abstract][Full Text] [Related]
2. A decision aid to assist in adjuvant therapy choices for breast cancer. Siminoff LA; Gordon NH; Silverman P; Budd T; Ravdin PM Psychooncology; 2006 Nov; 15(11):1001-13. PubMed ID: 16511899 [TBL] [Abstract][Full Text] [Related]
3. Dissemination of adjuvant multiagent chemotherapy and tamoxifen for breast cancer in the United States using estrogen receptor information: 1975-1999. Mariotto AB; Feuer EJ; Harlan LC; Abrams J J Natl Cancer Inst Monogr; 2006; (36):7-15. PubMed ID: 17032888 [TBL] [Abstract][Full Text] [Related]
4. Adjuvant treatment recommendations in older women with breast cancer: a survey of oncologists. Hurria A; Naeim A; Elkin E; Limaye S; Grover A; Hudis C; Pearce C; Robson M Crit Rev Oncol Hematol; 2007 Mar; 61(3):255-60. PubMed ID: 17098441 [TBL] [Abstract][Full Text] [Related]
5. Older age predicts a decline in adjuvant chemotherapy recommendations for patients with breast carcinoma: evidence from a tertiary care cohort of chemotherapy-eligible patients. DeMichele A; Putt M; Zhang Y; Glick JH; Norman S Cancer; 2003 May; 97(9):2150-9. PubMed ID: 12712466 [TBL] [Abstract][Full Text] [Related]
6. A computer based program to assist in adjuvant therapy decisions for individual breast cancer patients. Ravdin PM Bull Cancer; 1995 Dec; 82 Suppl 5():561s-564s. PubMed ID: 8680066 [TBL] [Abstract][Full Text] [Related]
7. Utility of a web-based breast cancer predictive algorithm for adjuvant chemotherapeutic decision making in a multidisciplinary oncology center. Epstein RJ; Leung TW; Mak J; Cheung PS Cancer Invest; 2006; 24(4):367-73. PubMed ID: 16777688 [TBL] [Abstract][Full Text] [Related]
8. Pilot trial of a computerized decision aid for breast cancer prevention. Ozanne EM; Annis C; Adduci K; Showstack J; Esserman L Breast J; 2007; 13(2):147-54. PubMed ID: 17319855 [TBL] [Abstract][Full Text] [Related]
9. Is adjuvant therapy for older patients with node (+) early breast cancer cost-effective? Naeim A; Keeler EB Breast Cancer Res Treat; 2005 Nov; 94(2):95-103. PubMed ID: 16261407 [TBL] [Abstract][Full Text] [Related]
10. The impact of tumor progesterone receptor status on optimal adjuvant endocrine therapy for postmenopausal patients with early-stage breast cancer: a decision analysis. Punglia RS; Kuntz KM; Winer EP; Weeks JC; Burstein HJ Cancer; 2006 Jun; 106(12):2576-82. PubMed ID: 16703595 [TBL] [Abstract][Full Text] [Related]
11. Breast cancer disparities and decision-making among U.S. women. Polacek GN; Ramos MC; Ferrer RL Patient Educ Couns; 2007 Feb; 65(2):158-65. PubMed ID: 16870385 [TBL] [Abstract][Full Text] [Related]
12. Impact of providing audiotapes of primary adjuvant treatment consultations to women with breast cancer: a multisite, randomized, controlled trial. Hack TF; Pickles T; Bultz BD; Ruether JD; Weir LM; Degner LF; Mackey JR J Clin Oncol; 2003 Nov; 21(22):4138-44. PubMed ID: 14615442 [TBL] [Abstract][Full Text] [Related]
13. Physicians' reasons for failing to deliver effective breast cancer care: a framework for underuse. Bickell NA; McEvoy MD Med Care; 2003 Mar; 41(3):442-6. PubMed ID: 12618647 [TBL] [Abstract][Full Text] [Related]
14. Healthy women with a family history of breast cancer: impact of a tailored genetic counseling intervention on risk perception, knowledge, and menopausal therapy decision making. Matloff ET; Moyer A; Shannon KM; Niendorf KB; Col NF J Womens Health (Larchmt); 2006 Sep; 15(7):843-56. PubMed ID: 16999640 [TBL] [Abstract][Full Text] [Related]
15. Effectiveness of a letter notification program for women with early-stage breast cancer eligible for extended adjuvant letrozole. McArthur HL; Gelmon KA; Olivotto IA; Speers CH; Ellard SL; O'Reilly SE; Kennecke HF J Clin Oncol; 2009 Mar; 27(9):1388-93. PubMed ID: 19237634 [TBL] [Abstract][Full Text] [Related]
16. Outcome prediction for estrogen receptor-positive breast cancer based on postneoadjuvant endocrine therapy tumor characteristics. Ellis MJ; Tao Y; Luo J; A'Hern R; Evans DB; Bhatnagar AS; Chaudri Ross HA; von Kameke A; Miller WR; Smith I; Eiermann W; Dowsett M J Natl Cancer Inst; 2008 Oct; 100(19):1380-8. PubMed ID: 18812550 [TBL] [Abstract][Full Text] [Related]
17. Assessment of care by breast cancer patients participating or not participating in a randomized controlled trial: a report with the Patients' Committee for Clinical Trials of the Ligue Nationale Contre le Cancer. Julian-Reynier C; Genève J; Dalenc F; Genre D; Monnier A; Kerbrat P; Largillier R; Serin D; Rios M; Roché H; Jimenez M; Tarpin C; Maraninchi D; J Clin Oncol; 2007 Jul; 25(21):3038-44. PubMed ID: 17536083 [TBL] [Abstract][Full Text] [Related]
18. Are all aromatase inhibitors the same? A review of controlled clinical trials in breast cancer. Berry J Clin Ther; 2005 Nov; 27(11):1671-84. PubMed ID: 16368441 [TBL] [Abstract][Full Text] [Related]
19. Entertainment education for breast cancer surgery decisions: a randomized trial among patients with low health literacy. Jibaja-Weiss ML; Volk RJ; Granchi TS; Neff NE; Robinson EK; Spann SJ; Aoki N; Friedman LC; Beck JR Patient Educ Couns; 2011 Jul; 84(1):41-8. PubMed ID: 20609546 [TBL] [Abstract][Full Text] [Related]
20. The effects of a shared decision-making intervention in primary care of depression: a cluster-randomized controlled trial. Loh A; Simon D; Wills CE; Kriston L; Niebling W; Härter M Patient Educ Couns; 2007 Aug; 67(3):324-32. PubMed ID: 17509808 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]